$LUMO
Lumos Pharma Inc Stock $lumo

$lumo Overview Financials Valuation SEC Filings Company Website

2011 Q4 Form 10-K Financial Statement

#000112623412000014 Filed on March 30, 2012

Income Statement

Concept	2011 Q4	2011	2010 Q4
Revenue	$301.0K	$1.872M	$1.000M
YoY Change	-69.9%	-9.96%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.100M	$5.700M	$2.300M
YoY Change	-8.7%	-6.56%
% of Gross Profit
Research & Development	$4.000M	$14.26M	$3.000M
YoY Change	33.33%	12.55%
% of Gross Profit
Depreciation & Amortization	$200.0K	$687.0K	$300.0K
YoY Change	-33.33%	4.89%
% of Gross Profit
Operating Expenses	$6.100M	$19.93M	$5.300M
YoY Change	15.09%	6.37%
Operating Profit	-$5.804M	-$18.06M
YoY Change		8.41%
Interest Expense	$0.00	$0.00	$0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net	$0.00	-$26.00K	$0.00
YoY Change		-126.26%
Pretax Income	-$5.800M	-$18.09M	-$4.300M
YoY Change	34.88%	8.96%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$5.810M	-$18.09M	-$4.100M
YoY Change	41.71%	11.56%
Net Earnings / Revenue	-1930.23%	-966.19%	-410.0%
Basic Earnings Per Share	-$0.44
Diluted Earnings Per Share	-$3.867M	-$25.86M	-$1.783M
COMMON SHARES
Basic Shares Outstanding	20.66M shares	6.065M shares
Diluted Shares Outstanding		6.065M shares

Balance Sheet

Concept	2011 Q4	2011	2010 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$42.00M	$42.00M	$12.80M
YoY Change	228.13%	228.13%
Cash & Equivalents	$39.49M	$39.50M	$10.57M
Short-Term Investments	$2.500M	$2.500M	$2.300M
Other Short-Term Assets	$400.0K	$400.0K	$1.000M
YoY Change	-60.0%	-60.0%
Inventory
Prepaid Expenses	$409.0K		$959.0K
Receivables
Other Receivables
Total Short-Term Assets	$42.79M	$42.80M	$14.64M
YoY Change	192.23%	193.15%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.591M	$5.600M	$5.436M
YoY Change	2.85%	3.7%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$5.591M	$5.600M	$5.436M
YoY Change	2.85%	1.82%
TOTAL ASSETS
Total Short-Term Assets	$42.79M	$42.80M	$14.64M
Total Long-Term Assets	$5.591M	$5.600M	$5.436M
Total Assets	$48.38M	$48.40M	$20.08M
YoY Change	140.96%	140.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.670M	$1.700M	$552.0K
YoY Change	202.54%	183.33%
Accrued Expenses	$1.867M	$1.900M	$1.554M
YoY Change	20.14%	18.75%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$93.00K	$6.200M	$91.00K
YoY Change	2.2%	3000.0%
Total Short-Term Liabilities	$10.66M	$10.70M	$3.265M
YoY Change	226.62%	224.24%
LONG-TERM LIABILITIES
Long-Term Debt	$900.0K	$900.0K	$7.100M
YoY Change	-87.32%	-87.32%
Other Long-Term Liabilities	$0.00	$0.00
YoY Change
Total Long-Term Liabilities	$942.0K	$900.0K	$7.087M
YoY Change	-86.71%	-87.32%
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.66M	$10.70M	$3.265M
Total Long-Term Liabilities	$942.0K	$900.0K	$7.087M
Total Liabilities	$11.61M	$11.60M	$10.35M
YoY Change	12.11%	-12.78%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$206.0K		$36.00K
YoY Change	472.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$36.77M	$36.80M	-$54.96M
YoY Change
Total Liabilities & Shareholders Equity	$48.38M	$48.40M	$20.08M
YoY Change	140.96%	140.8%

Cashflow Statement

Concept	2011 Q4	2011	2010 Q4
OPERATING ACTIVITIES
Net Income	-$5.810M	-$18.09M	-$4.100M
YoY Change	41.71%	11.56%
Depreciation, Depletion And Amortization	$200.0K	$687.0K	$300.0K
YoY Change	-33.33%	4.89%
Cash From Operating Activities	-$1.600M	-$12.95M	-$3.900M
YoY Change	-58.97%	-2.42%
INVESTING ACTIVITIES
Capital Expenditures	-$200.0K	$281.0K	$0.00
YoY Change		-90.42%
Acquisitions		$0.00
YoY Change
Other Investing Activities	-$2.500M	-$200.0K	-$700.0K
YoY Change	257.14%	-200.0%
Cash From Investing Activities	-$2.700M	-$502.0K	-$700.0K
YoY Change	285.71%	-81.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		-$37.59M
YoY Change		2228.81%
Debt Paid & Issued, Net		$92.00K
YoY Change		37.31%
Cash From Financing Activities	37.50M	$42.37M	9.300M
YoY Change	303.23%	273.82%
NET CHANGE
Cash From Operating Activities	-1.600M	-$12.95M	-3.900M
Cash From Investing Activities	-2.700M	-$502.0K	-700.0K
Cash From Financing Activities	37.50M	$42.37M	9.300M
Net Change In Cash	33.20M	$28.92M	4.700M
YoY Change	606.38%	-722.56%
FREE CASH FLOW
Cash From Operating Activities	-$1.600M	-$12.95M	-$3.900M
Capital Expenditures	-$200.0K	$281.0K	$0.00
Free Cash Flow	-$1.400M	-$13.23M	-$3.900M
YoY Change	-64.1%	-18.34%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	159000	USD
CY2010Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	604000	USD
CY2011Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2911000	USD
CY2010Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2224000	USD
CY2011Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	196000	USD
CY2011Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1670000	USD
CY2010Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	552000	USD
CY2010Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1554000	USD
CY2011Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1867000	USD
CY2011Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	118043000	USD
CY2010Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	7374000	USD
CY2011Q4	us-gaap	Assets Assets	48379000	USD
CY2010Q4	us-gaap	Assets Assets	20078000	USD
CY2010Q4	us-gaap	Assets Current AssetsCurrent	14642000	USD
CY2011Q4	us-gaap	Assets Current AssetsCurrent	42788000	USD
CY2009	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	749000	USD
CY2010	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	USD
CY2011	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	481000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1251000	USD
CY2011Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	121000	USD
CY2010Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	116000	USD
CY2010Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	145000	USD
CY2011Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	94000	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10572000	USD
CY2009Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15217000	USD
CY2008Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6276000	USD
CY1999Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39490000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	39490000	USD
CY2009	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	8941000	USD
CY2010	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-4645000	USD
CY2011	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	28918000	USD
CY2010Q4	us-gaap	Certificates Of Deposit At Carrying Value CertificatesOfDepositAtCarryingValue	2269000	USD
CY2011Q4	us-gaap	Certificates Of Deposit At Carrying Value CertificatesOfDepositAtCarryingValue	2490000	USD
CY2010Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2011Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3113000	USD
CY2009	us-gaap	Investment Income Interest InvestmentIncomeInterest	132000	USD
CY2010Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2011Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2010Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	38833334	shares
CY2011Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	38833334	shares
CY2010Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3628082	shares
CY2011Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20662029	shares
CY2010Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3628082	shares
CY2011Q4	us-gaap	Common Stock Value CommonStockValue	206000	USD
CY2010Q4	us-gaap	Common Stock Value CommonStockValue	36000	USD
CY2009	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	0	USD
CY2011	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	0	USD
CY2010	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	0	USD
	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	-449000	USD
CY2011Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	913000	USD
CY2010Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	951000	USD
CY2009	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	303000	USD
CY2010	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	655000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2961000	USD
CY2011	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	687000	USD
CY2011Q4	us-gaap	Development Stage Enterprise Deficit Accumulated During Development Stage DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage	-81476000	USD
CY2010Q4	us-gaap	Development Stage Enterprise Deficit Accumulated During Development Stage DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage	-63389000	USD
CY2009	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-3.16
CY2011	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.98
CY2010	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-4.84
CY2009	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	114000	USD
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	542000	USD
CY2011	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	80000	USD
CY2010	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	282000	USD
CY2010	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	USD
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-8800000	USD
CY2011	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-2269000	USD
CY2009	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	USD
CY2009	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	449000	USD
CY2011	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2010	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2009	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3705000	USD
CY2011	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5679000	USD
CY2010	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6074000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	29835000	USD
CY2009	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-271000	USD
CY2010	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-528000	USD
CY2011	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	637000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	440000	USD
CY2011	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-8000	USD
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	0	USD
CY2009	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	23000	USD
CY2010	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-60000	USD
CY2010	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	382000	USD
CY2009	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1201000	USD
CY2011	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	276000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2781000	USD
CY2009	us-gaap	Increase Decrease In Notes Receivable Related Parties IncreaseDecreaseInNotesReceivableRelatedParties	0	USD
CY2010	us-gaap	Increase Decrease In Notes Receivable Related Parties IncreaseDecreaseInNotesReceivableRelatedParties	-500000	USD
	us-gaap	Increase Decrease In Notes Receivable Related Parties IncreaseDecreaseInNotesReceivableRelatedParties	350000	USD
CY2011	us-gaap	Increase Decrease In Notes Receivable Related Parties IncreaseDecreaseInNotesReceivableRelatedParties	0	USD
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	196000	USD
CY2010	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-737000	USD
CY2009	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	1341000	USD
CY2011	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-408000	USD
CY2009	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	60000	USD
CY2010	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	849000	USD
CY2011	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-550000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	409000	USD
CY2011	us-gaap	Interest Expense Debt InterestExpenseDebt	42000	USD
CY2010	us-gaap	Interest Expense Debt InterestExpenseDebt	47000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	143000	USD
CY2009	us-gaap	Interest Expense Debt InterestExpenseDebt	9000	USD
CY2010	us-gaap	Interest Paid InterestPaid	44000	USD
	us-gaap	Interest Paid InterestPaid	104000	USD
CY2009	us-gaap	Interest Paid InterestPaid	9000	USD
CY2011	us-gaap	Interest Paid InterestPaid	42000	USD
CY2011Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	1000	USD
CY2010Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	8000	USD
CY2011	us-gaap	Investment Income Interest InvestmentIncomeInterest	11000	USD
CY2010	us-gaap	Investment Income Interest InvestmentIncomeInterest	75000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1753000	USD
CY2011	us-gaap	Operating Expenses OperatingExpenses	19934000	USD
CY2011Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	4459000	USD
CY2010Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3804000	USD
CY2011Q4	us-gaap	Liabilities Liabilities	11606000	USD
CY2010Q4	us-gaap	Liabilities Liabilities	10352000	USD
CY2011Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	48379000	USD
CY2010Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20078000	USD
CY2010Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3265000	USD
CY2011Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10664000	USD
CY2011Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	942000	USD
CY2010Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	7087000	USD
CY2011Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	93000	USD
CY2010Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	91000	USD
CY2010Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	3165000	USD
CY2011Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	3333000	USD
CY2011Q4	us-gaap	Minority Interest MinorityInterest	0	USD
CY2010Q4	us-gaap	Minority Interest MinorityInterest	2943000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	118984000	USD
CY2010	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	11334000	USD
CY2009	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	19626000	USD
CY2011	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	42369000	USD
CY2011	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-502000	USD
CY2009	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1545000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-9729000	USD
CY2010	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2709000	USD
CY2010	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13270000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-69765000	USD
CY2009	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9140000	USD
CY2011	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12949000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-81436000	USD
CY2011	us-gaap	Net Income Loss NetIncomeLoss	-18087000	USD
CY2010	us-gaap	Net Income Loss NetIncomeLoss	-16213000	USD
CY2009	us-gaap	Net Income Loss NetIncomeLoss	-9974000	USD
CY2011	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1000	USD
CY2010	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-349000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-583000	USD
CY2009	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-233000	USD
CY2005	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	2278000	USD
CY2007	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	8000	USD
CY2006	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	257000	USD
CY2008	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	-1000	USD
CY2011	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	-8634000	USD
CY2011Q4	us-gaap	Notes Payable Current NotesPayableCurrent	6000000	USD
CY2010Q4	us-gaap	Notes Payable Current NotesPayableCurrent	0	USD
CY2010	us-gaap	Operating Expenses OperatingExpenses	18740000	USD
	us-gaap	Operating Expenses OperatingExpenses	90153000	USD
CY2009	us-gaap	Operating Expenses OperatingExpenses	11283000	USD
CY2011	us-gaap	Operating Income Loss OperatingIncomeLoss	-18062000	USD
CY2009	us-gaap	Operating Income Loss OperatingIncomeLoss	-10349000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-84436000	USD
CY2010	us-gaap	Operating Income Loss OperatingIncomeLoss	-16661000	USD
CY2009	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	19000	USD
CY2010	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	71000	USD
CY2011	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	5000	USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	358000	USD
CY2009	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	142000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2417000	USD
CY2011	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-26000	USD
CY2010	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	99000	USD
CY2009	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2011	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	501000	USD
CY2010	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	468000	USD
CY2011	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2010	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2009	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	120000	USD
CY2011	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	2490000	USD
CY2010	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	277000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	11290000	USD
CY2009	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	142000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6769000	USD
CY2011	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	281000	USD
CY2010	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2932000	USD
CY2009	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1403000	USD
CY2004	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	5000	USD
CY2005	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	82000	USD
CY2003	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	5000	USD
CY2002	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	6000	USD
CY2006	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	4000	USD
CY2011	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	8000	USD
CY2010	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	2000	USD
CY2011Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	409000	USD
CY2010Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	959000	USD
CY2009	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	37747000	USD
CY2010	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2011	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	37555000	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	67743000	USD
CY2010	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	7723000	USD
CY2009	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	19580000	USD
CY2011	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	5000000	USD
CY2009	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	40000	USD
CY2010	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	911000	USD
CY2011	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	USD
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	3479000	USD
CY2009	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
CY2011	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	7759000	USD
CY2010	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1100000	USD
CY2002	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	13000	USD
CY2008	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	19000	USD
CY2009	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2007	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	12000	USD
CY2011	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	19000	USD
CY2010	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	2000000	USD
CY2010	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	82000	USD
CY2009	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	15000	USD
CY2011	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2009	us-gaap	Profit Loss ProfitLoss	-10207000	USD
CY2010	us-gaap	Profit Loss ProfitLoss	-16562000	USD
CY2011	us-gaap	Profit Loss ProfitLoss	-18088000	USD
	us-gaap	Profit Loss ProfitLoss	-82019000	USD
CY2003	us-gaap	Profit Loss ProfitLoss	-2979000	USD
CY2005	us-gaap	Profit Loss ProfitLoss	-4770000	USD
CY2004	us-gaap	Profit Loss ProfitLoss	-3669000	USD
	us-gaap	Profit Loss ProfitLoss	-64000	USD
CY2000	us-gaap	Profit Loss ProfitLoss	-236000	USD
CY2002	us-gaap	Profit Loss ProfitLoss	-2253000	USD
CY2001	us-gaap	Profit Loss ProfitLoss	-1448000	USD
CY2006	us-gaap	Profit Loss ProfitLoss	-5318000	USD
CY2008	us-gaap	Profit Loss ProfitLoss	-8842000	USD
CY2007	us-gaap	Profit Loss ProfitLoss	-7582000	USD
CY2010Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7660000	USD
CY2011Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8502000	USD
CY2010Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5436000	USD
CY2011Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5591000	USD
CY2011Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	710000	USD
CY2010Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	691000	USD
CY2011Q4	us-gaap	Receivable From Officers And Directors For Issuance Of Capital Stock ReceivableFromOfficersAndDirectorsForIssuanceOfCapitalStock	0	USD
CY2010Q4	us-gaap	Receivable From Officers And Directors For Issuance Of Capital Stock ReceivableFromOfficersAndDirectorsForIssuanceOfCapitalStock	-13000	USD
CY2011	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	126000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	287000	USD
CY2009	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	9000	USD
CY2010	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	93000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	369000	USD
CY2011	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	92000	USD
CY2009	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2010	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	67000	USD
CY2011	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14255000	USD
CY2010	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12666000	USD
CY2009	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7578000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	60318000	USD
CY2010	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	819000	USD
	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	1428000	USD
CY2011	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	0	USD
CY2000Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	776000	USD
CY2002Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2836000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	5349000	USD
CY2010	us-gaap	Share Based Compensation ShareBasedCompensation	1525000	USD
CY2009	us-gaap	Share Based Compensation ShareBasedCompensation	929000	USD
CY2011	us-gaap	Share Based Compensation ShareBasedCompensation	2545000	USD
CY2003	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	15000	USD
CY2009	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	0	USD
CY2010	us-gaap	Revenue From Grants RevenueFromGrants	2079000	USD
CY2009	us-gaap	Revenue From Grants RevenueFromGrants	934000	USD
CY2011	us-gaap	Revenue From Grants RevenueFromGrants	1872000	USD
	us-gaap	Revenue From Grants RevenueFromGrants	5717000	USD
CY2004	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	57000	USD
CY2005	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	2000	USD
CY2002	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	14000	USD
	us-gaap	Stock Issued1 StockIssued1	1654000	USD
CY2009	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2011	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2010	us-gaap	Stock Issued1 StockIssued1	932000	USD
CY2005	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	354000	USD
CY2006	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	130000	USD
CY2010	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	819000	USD
CY2011	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	75390000	USD
CY2010	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	114000	USD
CY2000	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	47000	USD
CY2001	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	50000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	27000	USD
CY2011	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	37555000	USD
CY2009	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3000	USD
CY2010	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2000	USD
CY2005	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	51000	USD
CY2003	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	46000	USD
CY2006	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	22000	USD
CY2007	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	58000	USD
CY2008	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	86000	USD
CY2011	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2545000	USD
CY2010	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1525000	USD
CY2009	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	929000	USD
CY2010Q4	us-gaap	Stockholders Equity StockholdersEquity	-54962000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	36773000	USD
CY2011Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	36773000	USD
CY2010Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-52019000	USD
CY2003Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-4640000	USD
CY2004Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-8252000	USD
CY2005Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-10418000	USD
CY2001Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-637000	USD
CY1999Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-37000	USD
CY1999Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	0	USD
CY2008Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-31566000	USD
CY2006Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-15331000	USD
CY2007Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-22833000	USD
CY2009Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-40786000	USD
CY2011Q4	us-gaap	Temporary Equity Carrying Amount TemporaryEquityCarryingAmount	0	USD
CY2010Q4	us-gaap	Temporary Equity Carrying Amount TemporaryEquityCarryingAmount	61745000	USD
CY2010Q4	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	61782000	USD
CY2011Q4	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	0	USD
CY2010Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.01
CY2011Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.00
CY2011Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	0	shares
CY2010Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	15327777	shares
CY2010Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0	shares
CY2011Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0	shares
CY2010Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	13417435	shares
CY2011Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2001	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	-15000	USD
CY2010	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	-469000	USD
CY2010	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3352331	shares
CY2009	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3159993	shares
CY2011	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6064542	shares
CY2011	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6064542	shares
CY2009	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3159993	shares
CY2010	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3352331	shares
CY2009	nlnk	Accretion On Redeemable Preferred Stock AccretionOnRedeemablePreferredStock	0	USD
CY2011	nlnk	Accretion On Redeemable Preferred Stock AccretionOnRedeemablePreferredStock	-8000	USD
CY2010	nlnk	Accretion On Redeemable Preferred Stock AccretionOnRedeemablePreferredStock	-2000	USD
	nlnk	Accretion On Redeemable Preferred Stock AccretionOnRedeemablePreferredStock	-113000	USD
CY2004	nlnk	Adjustments To Equity For Receipt Of Payment On Notes Receivable For Common Stock AdjustmentsToEquityForReceiptOfPaymentOnNotesReceivableForCommonStock	5000	USD
CY2005	nlnk	Adjustments To Equity For Receipt Of Payment On Notes Receivable For Common Stock AdjustmentsToEquityForReceiptOfPaymentOnNotesReceivableForCommonStock	1000	USD
CY2003	nlnk	Adjustments To Equity For Receipt Of Payment On Notes Receivable For Common Stock AdjustmentsToEquityForReceiptOfPaymentOnNotesReceivableForCommonStock	7000	USD
CY2002	nlnk	Adjustments To Equity For Receipt Of Payment On Notes Receivable For Common Stock AdjustmentsToEquityForReceiptOfPaymentOnNotesReceivableForCommonStock	33000	USD
CY2000	nlnk	Adjustments To Equity For Receipt Of Payment On Notes Receivable For Common Stock AdjustmentsToEquityForReceiptOfPaymentOnNotesReceivableForCommonStock	13000	USD
CY2007	nlnk	Adjustments To Equity For Receipt Of Payment On Notes Receivable For Common Stock AdjustmentsToEquityForReceiptOfPaymentOnNotesReceivableForCommonStock	2000	USD
CY2011	nlnk	Adjustments To Equity For Receipt Of Payment On Notes Receivable For Common Stock AdjustmentsToEquityForReceiptOfPaymentOnNotesReceivableForCommonStock	13000	USD
CY2010	nlnk	Adjustments To Equity For Receipt Of Payment On Notes Receivable For Common Stock AdjustmentsToEquityForReceiptOfPaymentOnNotesReceivableForCommonStock	146000	USD
CY2010Q4	nlnk	Cash And Cash Equivalents Excluding Certificates Of Deposit CashAndCashEquivalentsExcludingCertificatesOfDeposit	10572000	USD
CY2011Q4	nlnk	Cash And Cash Equivalents Excluding Certificates Of Deposit CashAndCashEquivalentsExcludingCertificatesOfDeposit	39490000	USD
CY2011Q4	nlnk	Deposits On Restricted Shares DepositsOnRestrictedShares	0	USD
CY2010Q4	nlnk	Deposits On Restricted Shares DepositsOnRestrictedShares	1000	USD
CY2003	nlnk	Exercise Of Warrants ExerciseOfWarrants	1112000	USD
CY2010	nlnk	Exercise Of Warrants ExerciseOfWarrants	2000000	USD
	nlnk	Forgiveness Of Notes Receivable From Related Parties ForgivenessOfNotesReceivableFromRelatedParties	350000	USD
CY2011	nlnk	Forgiveness Of Notes Receivable From Related Parties ForgivenessOfNotesReceivableFromRelatedParties	0	USD
CY2009	nlnk	Forgiveness Of Notes Receivable From Related Parties ForgivenessOfNotesReceivableFromRelatedParties	0	USD
CY2010	nlnk	Forgiveness Of Notes Receivable From Related Parties ForgivenessOfNotesReceivableFromRelatedParties	350000	USD
CY2009	nlnk	In Process Research And Development Expenses InProcessResearchAndDevelopmentExpenses	0	USD
CY2011	nlnk	In Process Research And Development Expenses InProcessResearchAndDevelopmentExpenses	0	USD
	nlnk	In Process Research And Development Expenses InProcessResearchAndDevelopmentExpenses	201000	USD
CY2010	nlnk	In Process Research And Development Expenses InProcessResearchAndDevelopmentExpenses	201000	USD
	nlnk	Increase Decrease In State Research And Development Credit Receivable IncreaseDecreaseInStateResearchAndDevelopmentCreditReceivable	202000	USD
CY2010	nlnk	Increase Decrease In State Research And Development Credit Receivable IncreaseDecreaseInStateResearchAndDevelopmentCreditReceivable	60000	USD
CY2009	nlnk	Increase Decrease In State Research And Development Credit Receivable IncreaseDecreaseInStateResearchAndDevelopmentCreditReceivable	-329000	USD
CY2011	nlnk	Increase Decrease In State Research And Development Credit Receivable IncreaseDecreaseInStateResearchAndDevelopmentCreditReceivable	-28000	USD
CY2010	nlnk	Noncash Issuance Of Common Stock Dividend To Preferred Shareholders NoncashIssuanceOfCommonStockDividendToPreferredShareholders	1000	USD
	nlnk	Noncash Issuance Of Common Stock Dividend To Preferred Shareholders NoncashIssuanceOfCommonStockDividendToPreferredShareholders	6000	USD
CY2011	nlnk	Noncash Issuance Of Common Stock Dividend To Preferred Shareholders NoncashIssuanceOfCommonStockDividendToPreferredShareholders	1000	USD
CY2009	nlnk	Noncash Issuance Of Common Stock Dividend To Preferred Shareholders NoncashIssuanceOfCommonStockDividendToPreferredShareholders	1000	USD
CY2000	nlnk	Preferred Stock Issued PreferredStockIssued	989000	USD
CY2009	nlnk	Preferred Stock Issued PreferredStockIssued	-40000	USD
CY2010	nlnk	Preferred Stock Issued PreferredStockIssued	911000	USD
	nlnk	Proceeds From Subsidiary Common Stock Option Exercise ProceedsFromSubsidiaryCommonStockOptionExercise	141000	USD
CY2010	nlnk	Proceeds From Subsidiary Common Stock Option Exercise ProceedsFromSubsidiaryCommonStockOptionExercise	121000	USD
CY2009	nlnk	Proceeds From Subsidiary Common Stock Option Exercise ProceedsFromSubsidiaryCommonStockOptionExercise	0	USD
CY2011	nlnk	Proceeds From Subsidiary Common Stock Option Exercise ProceedsFromSubsidiaryCommonStockOptionExercise	0	USD
	nlnk	Repayments Advances Of Notes Receivable For Common Stock RepaymentsAdvancesOfNotesReceivableForCommonStock	0	USD
CY2010	nlnk	Repayments Advances Of Notes Receivable For Common Stock RepaymentsAdvancesOfNotesReceivableForCommonStock	-25000	USD
CY2011	nlnk	Repayments Advances Of Notes Receivable For Common Stock RepaymentsAdvancesOfNotesReceivableForCommonStock	-13000	USD
CY2009	nlnk	Repayments Advances Of Notes Receivable For Common Stock RepaymentsAdvancesOfNotesReceivableForCommonStock	0	USD
CY2010Q4	nlnk	State Research And Development Credit Receivable StateResearchAndDevelopmentCreditReceivable	230000	USD
CY2011Q4	nlnk	State Research And Development Credit Receivable StateResearchAndDevelopmentCreditReceivable	202000	USD
CY2008	nlnk	Stock Issued For Milestone StockIssuedForMilestone	5000	USD
CY2010	nlnk	Stock Issued For Milestone StockIssuedForMilestone	201000	USD
CY2011	dei	Amendment Flag AmendmentFlag	false
CY2011	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2011	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2011	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2011
CY2011	dei	Document Period End Date DocumentPeriodEndDate	2011-12-31
CY2011	dei	Document Type DocumentType	10-K
CY2011	dei	Entity Central Index Key EntityCentralIndexKey	0001126234
CY2011Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20662029	shares
CY2011	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2011	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2012Q1	dei	Entity Public Float EntityPublicFloat	122788546	USD
CY2011	dei	Entity Registrant Name EntityRegistrantName	NEWLINK GENETICS CORP
CY2011	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2011	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No

Files In Submission

Name	View Source	Status
0001126234-12-000014-index-headers.html	Edgar Link	pending
0001126234-12-000014-index.html	Edgar Link	pending
0001126234-12-000014.txt	Edgar Link	pending
0001126234-12-000014-xbrl.zip	Edgar Link	pending
alphagal.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
kmplot.jpg	Edgar Link	pending
logo.jpg	Edgar Link	pending
nlnk-20111231.xml	Edgar Link	completed
nlnk-20111231.xsd	Edgar Link	pending
nlnk-20111231x10k.htm	Edgar Link	pending
nlnk-20111231xex231.htm	Edgar Link	pending
nlnk-20111231xex311.htm	Edgar Link	pending
nlnk-20111231xex312.htm	Edgar Link	pending
nlnk-20111231xex321.htm	Edgar Link	pending
nlnk-20111231_cal.xml	Edgar Link	unprocessable
nlnk-20111231_def.xml	Edgar Link	unprocessable
nlnk-20111231_lab.xml	Edgar Link	unprocessable
nlnk-20111231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
returngraph.jpg	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LUMO
Lumos Pharma Inc Stock $lumo

2011 Q4 Form 10-K Financial Statement

#000112623412000014 Filed on March 30, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LUMO Lumos Pharma Inc Stock $lumo

2011 Q4 Form 10-K Financial Statement

#000112623412000014 Filed on March 30, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LUMO
Lumos Pharma Inc Stock $lumo